(3R)-4'-Methoxy-2',3',7-Trihydroxyisoflavanone

(3R)-4'-Methoxy-2',3',7-Trihydroxyisoflavanone

SCHEMBL572272

COc1ccc([C@@]2(O)COc3cc(O)ccc3C2=O)c(O)c1

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 1/20 0.61
MAOB P27338 2/20 0.46
CYP19A1 P11511 5/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA4 P22748 1/20 0.42
CA7 P43166 1/20 0.42
CA9 Q16790 1/20 0.42
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
GAA P10253 1/20 0.41
ALOX15 P16050 3/20 0.41
ALOX12 P18054 2/20 0.41
TYR P14679 1/20 0.41
KIT P10721 1/20 0.40
NR1H4 Q96RI1 1/20 0.40
CYP3A4 P08684 5/20 0.39
MAPT P10636 5/20 0.39
HPGD P15428 4/20 0.39
ALDH1A1 P00352 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
(3R)-4'-Methoxy-2',3',7-Trihydroxyisoflavanone SCHEMBL30217561 1.00 PTPN1 (0.61) PTPN1MAOBCYP19A1CA1CA2
(3R)-4'-Methoxy-2',3',7-Trihydroxyisoflavanone SCHEMBL17963716 1.00 PTPN1 (0.61) PTPN1MAOBCYP19A1CA1CA2
SCHEMBL29099783 0.85 PTPN1 (0.53) PTPN1MAOBCYP19A1CA1CA2
SCHEMBL28316491 0.85 PTPN1 (0.48) PTPN1MAOBCYP19A1CA1CA2
SCHEMBL29099779 0.77 PTPN1 (0.48) PTPN1MAOBCYP19A1MEN1KMT2A
SCHEMBL14100969 0.76 ACHE (0.48) PTPN1MEN1KMT2ATYRCYP3A4
SCHEMBL14100984 0.76 PTPN1 (0.43) PTPN1MEN1KMT2AGAACYP3A4
SCHEMBL17867146 0.75 PTPN1 (0.48) PTPN1MAOBCYP19A1CA1CA2
SCHEMBL501806 0.75 ALDH1A1 (0.41) PTPN1MAOBMEN1KMT2AGAA
SCHEMBL572273 0.75 NR1H4 (0.41) PTPN1MAOBMEN1KMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140234271-A1 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS THE HOSPITAL FOR SICK CHILDREN (CA) 2014-08-21 US disclosed
US-8748177-B2 Compositions for proliferation of cells and related methods THE HOSPITAL FOR SICK CHILDREN (CA) 2014-06-10 US disclosed
EP-2598150-A2 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS The Hospital For Sick Children (CA) 2013-06-05 EP disclosed
WO-2012018643-A2 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS THE HOSPITAL FOR SICK CHILDREN (CA) 2012-02-09 WO disclosed
US-20110301105-A1 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS THE HOSPITAL FOR SICK CHILDREN (CA) 2011-12-08 US disclosed
WO-2010039679-A1 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS THE HOSPITAL FOR SICK CHILDREN (CA) 2010-04-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140234271-A1 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS MKI67, KRT18, PROX1 PTPN1 3544/4885MAOB 3896/4885CYP19A1 529/4885
US-20110301105-A1 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS MKI67, KRT18, PROX1 PTPN1 3544/4885MAOB 3896/4885CYP19A1 529/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.